Health
Buck researchers investigate ketone bodies as possible therapeutic against COVID-19 – News-Medical.Net
Given the disproportionate impact that COVID-19 has on older adults in terms of death and lasting disability, and the impact of common aging-related comorbidities like diabetes and cardiovascular disease, Buck Institute professor and practicing geriatrician J…
Reviewed by Emily Henderson, B.Sc.Jul 15 2020
Given the disproportionate impact that COVID-19 has on older adults in terms of death and lasting disability, and the impact of common aging-related comorbidities like diabetes and cardiovascular disease, Buck Institute professor and practicing geriatrician John Newman, MD, PhD, can make a compelling argument that those infected with the SARS-CoV2 virus are suffering from an aging-related disease, no matter how old they are when they get infected.
…
-
Business21 hours agoBrokers name 3 quality ASX 200 shares to buy today
-
Noosa News17 hours agoFirst home buyers’ options to almost double under expanded Home Guarantee Scheme
-
Business19 hours agoMorgans says these ASX shares could rise 30%+
-
General23 hours agoExplosions heard in Qatar capital Doha, Israel announces strike on Hamas ‘senior leadership’